5Jeu L, Cheng JW. Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor [ J ]. Clin Ther, 2003,25(9) :2352.
6Salen G, yon Bergmann K, Lutjohann D, et al. Ezetimibe effectively reduces plasma plant sterois in patients with sitosterolemia[J]. Circulation ,2004,109(8) :966.
7Repa J, Dietschy J, Turley S . Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1 ,ABCG5 or ABCG8 in the enterocyte[J]. Lipid Res ,2002,43:1864.
8Altmann SW, Davis HR Jr, Yao X, et al. The identification of intestinal scavenger receptor class B type I (Sr-Bi)by expression cloning and its role in cholesterol absorption [ J ]. Biochim Biophys Acta,2002,1580:77.
9Knopp RH, Gitter H, Truitt T, et al. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipid in patients with primary hypercholesterolemia [J]. Eur Heart J,2003,24(8) :729.
10Lipka LJ. Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor[J]. Cardiovasc Drug Rev,2003,21(4):293.
